Prognostic factors in resected satellite-nodule T4 non-small cell lung cancer

被引:25
|
作者
Rao, Jagan
Sayeed, Rana A.
Tomaszek, Sandra
Fischer, Stefan
Keshavjee, Shaf
Darling, Gail E.
机构
[1] Univ Toronto, Toronto Gen Hosp, Div Thorac Surg, Univ Hlth Network, Toronto, ON M5G 2C4, Canada
[2] Univ Toronto, Princess Margaret Hosp, Div Thorac Surg, Univ Hlth Network, Toronto, ON M5G 2C4, Canada
来源
ANNALS OF THORACIC SURGERY | 2007年 / 84卷 / 03期
关键词
D O I
10.1016/j.athoracsur.2007.04.097
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The 1997 non-small cell lung cancer staging revisions assigned a T4 descriptor to satellite nodules in the primary tumor lobe. We reviewed our experience of satellite-nodule T4 non-small cell lung cancer following these revisions and evaluated prognostic factors for this group. Methods. All patients who underwent resection of non-small cell lung cancer between April 1997 and June 2005 with satellite nodule(s) confirmed at pathologic examination were identified from our institutional Lung Tumor Registry. Case notes and pathology reports were reviewed and data collected on possible prognostic factors. Survival was modeled using the Kaplan-Meier method, and survival differences between groups were analyzed using the log-rank test. Results. From 1,276 non-small cell lung cancer patients who underwent resection, 137 were staged pT4, and 35 were T4-satellite nodules. Median follow-up was 25 months ( range, 1 to 102 months). Median main tumor size was 3.0 cm ( range, 1 to 9.8 cm). Adenocarcinoma or bronchioloalveolar carcinoma was the predominant histologic diagnosis (n = 28; 80%). One-, 3- and 5-year survival was 86%, 69%, and 57%, respectively; median survival was 68 months. During the same period, 137 patients undergoing resection for all T4 lesions had a 1-, 3-, and 5-year survival of 68%, 53%, and 18%, respectively. Adenocarcinoma or bronchioloalveolar carcinoma histologic diagnosis ( adenocarcinoma or bronchioloalveolar carcinoma versus squamous, 75% versus 67% 3- year survival; p = 0.0026), female gender (66% versus 49% for males, 5-year survival; p = 0.041), and absence of vascular invasion ( no invasion versus vascular invasion, 74% versus 20% 5-year survival; p = 0.0101) were significant predictors of better survival. Conclusions. Survival for resected T4 non-small cell lung cancer with satellite nodule(s) in the primary lobe is better than for other T4 lesions, and the T4 descriptor may unduly upstage these cases. The current T4 descriptor represents a heterogeneous population.
引用
收藏
页码:934 / 939
页数:6
相关论文
共 50 条
  • [41] LYMPHOVASCULAR INVASION AS A PROGNOSTIC FACTOR IN NON-SMALL CELL LUNG CANCER PATIENTS WITH PATHOLOGIC T4 SEPARATE TUMOR NODULE IN A DIFFERENT IPSILATERAL LOBE.
    Leon, Jae Ilyun
    Kong, Chang H.
    Kim, Hye S.
    Seong, Yong W.
    Park, In K.
    Kim, Young T.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S477 - S477
  • [42] Prognostic factors in non-small cell lung cancer surgery
    Birim, Ö
    Kappetein, AP
    van Klaveren, R
    Bogers, AMC
    EJSO, 2006, 32 (01): : 12 - 23
  • [43] Prognostic factors for patients with non-small cell lung cancer
    Rosvold, E
    CURRENT PROBLEMS IN CANCER, 1996, 20 (04) : 272 - 278
  • [44] Prognostic factors in resected Stage I and II non-small lung cancer (NSCLC)
    Mauro, Laura V.
    Dallurzo, Liliana
    Smith, David
    Veloso, Maria J.
    Lastiri, Jose
    Vasallo, Bartolome
    Pallotta, Maria G.
    de Kier Joffe, Elisa D. Bal
    Puricelli, Lydia
    CANCER RESEARCH, 2006, 66 (08)
  • [45] Prognostic factors in completely resected stage IB non-small cell lung cancer with a diameter of 4cm or more
    Okamoto, Junichi
    Hioki, Masafumi
    Kubokura, Hirotoshi
    Mikami, Iwao
    Hirata, Tomomi
    Haraguchi, Shuji
    Koizumi, Kiyoshi
    Shimizu, Kazuo
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S789 - S789
  • [46] Adjuvant Chemotherapy for T4 Non-Small Cell Lung Cancer with Additional Ipsilateral Lung Nodules
    Li, Andrew X.
    Flores, Kaitlin
    Canavan, Maureen E.
    Boffa, Daniel J.
    Blasberg, Justin D.
    ANNALS OF THORACIC SURGERY, 2022, 113 (02): : 421 - 428
  • [47] Surveillance of resected non-small cell lung cancer
    A. López-González
    P. Ibeas Millán
    B. Cantos
    M. Provencio
    Clinical and Translational Oncology, 2012, 14 : 721 - 725
  • [48] Surveillance of resected non-small cell lung cancer
    Lopez-Gonzalez, A.
    Ibeas Millan, P.
    Cantos, B.
    Provencio, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (10): : 721 - 725
  • [49] Prognostic factors in resected T3 non-small cell lung carcinoma: Perineural invasion as a new prognostic factor
    Demir, A.
    Gunluoglu, M. Z.
    Kara, H. V.
    Buyukpinarbasili, N.
    Dincer, S. I.
    THORACIC AND CARDIOVASCULAR SURGEON, 2008, 56 (02): : 93 - 98
  • [50] The Prognostic Impact of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer
    Shuichi Shinohara
    Ryo Otsuki
    Kenichi Kobayashi
    Masaki Matsuo
    Ken Harada
    Masakazu Sugaya
    Makoto Nakagawa
    Annals of Surgical Oncology, 2020, 27 : 481 - 489